BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11171557)

  • 1. Loss of skeletal muscle in cancer: biochemical mechanisms.
    Tisdale MJ
    Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic and local mechanisms leading to cachexia in cancer].
    Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer anorexia and cachexia.
    Tisdale MJ
    Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of muscle protein degradation induced by a cancer cachectic factor.
    Lorite MJ; Thompson MG; Drake JL; Carling G; Tisdale MJ
    Br J Cancer; 1998 Oct; 78(7):850-6. PubMed ID: 9764574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical mechanisms of cellular catabolism.
    Tisdale MJ
    Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):401-5. PubMed ID: 12107376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
    Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
    Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cachexia.
    Tisdale MJ
    Langenbecks Arch Surg; 2004 Aug; 389(4):299-305. PubMed ID: 15168125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catabolic mediators of cancer cachexia.
    Tisdale MJ
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):256-61. PubMed ID: 19069310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α and cancer cachexia: Molecular insights and clinical implications.
    Patel HJ; Patel BM
    Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
    Mirza KA; Pereira SL; Voss AC; Tisdale MJ
    Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of cachexia.
    Tisdale MJ
    J Natl Cancer Inst; 1997 Dec; 89(23):1763-73. PubMed ID: 9392617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catabolism of skeletal muscle proteins and its reversal in cancer cachexia.
    Tisdale MJ
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():135-43; discussion 144-6. PubMed ID: 11490570
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
    Sanders PM; Russell ST; Tisdale MJ
    Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF).
    Lorite MJ; Smith HJ; Arnold JA; Morris A; Thompson MG; Tisdale MJ
    Br J Cancer; 2001 Jul; 85(2):297-302. PubMed ID: 11461093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia.
    Baracos VE
    Nutrition; 2000 Oct; 16(10):1015-8. PubMed ID: 11054610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice.
    Llovera M; García-Martínez C; López-Soriano J; Carbó N; Agell N; López-Soriano FJ; Argiles JM
    Mol Cell Endocrinol; 1998 Jul; 142(1-2):183-9. PubMed ID: 9783914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomedicine. Protein loss in cancer cachexia.
    Tisdale MJ
    Science; 2000 Sep; 289(5488):2293-4. PubMed ID: 11041796
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
    Attaix D; Combaret L; Tilignac T; Taillandier D
    Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.